Supercritical Fluid Chiral Separations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Supercritical Fluid Chiral Separations
The combination of supercritical fluid chromatography with chiral separation media offers several analytival advantages over traditional liquid chromatography techniques.


Pharmaceutical Technology


In progress

Productivity will play a big role in future advances in SFC chiral methods. Much of the problem in progressing the technique stems from the fact that a lot of SCF work so far has been conducted with proprietary compounds and information is not available.

Regis scientists are conducting studies involving different chiral phases from two manufacturers, with one column in a series being used for mixing. "I think the biggest improvements will come in the machinery. Advances in the machinery and feedback from companies will move the technology forward," says Mannerino. "When a manufacturer does research, it a completely different story than when it is done in other settings. We are in constant communication with equipment manufacturers."

As with any chromatographic technique, continued compliance with US Food and Drug Administration regulations is an issue. For this reason, the approval of SFC chiral methods is another important factor in its success. "A validated synthesis will always be favorable over a chromatographic technique, even when it doesn't make sense financially or scientifically,"says Mannerino. Perhaps the greatest obstacle, however, is convincing high-level personnel. "It's just fighting old-school thinking,"he says. have a lot of upper management in companies that didn't grow up with advanced chromatography techniques, and they didn't go to school or internships with it. There are so many variables that you can't explain in chromatography, and so in their eyes it's not a reliable technique. Many organic chemists won't buy into it. It's changing slowly."

This article is based on an interview with Francis Mannerino, director of chromatography at Regis Technologies (Morton Grove, IL).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here